Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listX 14868A

X 14868A

  • CAS NO.:79356-08-4
  • Empirical Formula: C47H80O17
  • Molecular Weight: 917.13
  • MDL number: MFCD00865282
  • Update Date: 2023-05-21 10:59:17
X 14868A Structural

What is X 14868A?

The Uses of X 14868A

Maduramicin is a polyether antibiotic first isolated from Actinomadura yunnaense (formerly Nocardia sp. X-14868) in 1963. Maduramicin is a broad spectrum anticoccidial also active against Treponema and Cryptosporidium. Maduramicin is an ionophore, forming complexes with monovalent cations, with a higher affinity for K+ than Na+. Maduramicin is used as the ammonium salt in animals to prevent coccidiosis and to promote growth.

The Uses of X 14868A

Maduramicin is a broad-spectrum anticoccidial.

What are the applications of Application

Maduramicin is a broad-spectrum anticoccidial

Biological Activity

maduramicin, a natural polyether antibiotic, is cytotoxic against cryptosporidium spp. and plasmodium gametocytes, isolated from the actinomycete actinomadura rubra. as a broad-spectrum anticoccidial, maduramicin, which is commonly used in veterinary medicine as an anti-coccidial agent, is active against treponema and cryptosporidium. maduramicin is an ionophore which can form complexes with monovalent cations with a higher affinity for k+ than na+.

in vitro

maduramicin concentration-dependently blocked cell growth and inhibited cell proliferation in a concentration- and time-dependent fashion in skeletal muscle cells, mouse myoblasts (c2c12) and human rhabdomyosarcoma (rd and rh30) cells. also, maduramicin triggered cleavage of poly adp ribose polymerase in a concentration-dependent manner, which was the hallmark of caspase-dependent apoptosis in c2c12 and rd cells. it was determined that maduramicin caused cell death via caspase-dependent and -independent manner in c2c12 cells [2].

in vivo

severe combined immune deficient (scid) mice were administered with maduramicin at 3 mg/kg of body weight per day by oral gavage for 28 days. maduramicin treatment decreased the fecal parasite load after 21 days of treatment. also, maduramicin treatment elicited weight loss in scid mice. in addition, maduramicin exerted remarkable anticryptosporidial activities with concomitant moderate toxicity on scid mice [3].

References

[1]. gutiérrez-lugo, m., lotina-hennsen, b., farrés, a., sánchez, s., & mata, r. phytotoxic and photosynthetic activities of maduramicin and maduramicin methyl ester. zeitschrift für naturforschung c. 1999; 54(5-6).
[2]. chen, x., gu, y., singh, k., shang, c., barzegar, m., jiang, s., & huang, s. maduramicin inhibits proliferation and induces apoptosis in myoblast cells. plos one.2014; 9(12): e115652.
[3]. mead, j., you, x., pharr, j., belenkaya, y., arrowood, m., fallon, m., & schinazi, r. evaluation of maduramicin and alborixin in a scid mouse model of chronic cryptosporidiosis. antimicrobial agents and chemotherapy. 1995; 39(4): 854-858.

Properties of X 14868A

Boiling point: 913.9±65.0 °C(Predicted)
Density  1.25±0.1 g/cm3(Predicted)
storage temp.  Store at -20°C
solubility  Soluble in DMSO
form  solid
pka 4.38±0.10(Predicted)

Safety information for X 14868A

Computed Descriptors for X 14868A

You may like

  • Bendamustine deschloroethyl acid ethyl ester 2517968-40-8 NLT 95%
    Bendamustine deschloroethyl acid ethyl ester 2517968-40-8 NLT 95%
    2517968-40-8
    View Details
  • Acebutolol EP Impurity K NLT 95%
    Acebutolol EP Impurity K NLT 95%
    74143-33-2
    View Details
  • Clidinium Bromide Impurity NLT 95%
    Clidinium Bromide Impurity NLT 95%
    .6581-06-2
    View Details
  • 192110-67-2 NLT 95%
    192110-67-2 NLT 95%
    192110-67-2
    View Details
  • Cetirizine EP Impurity A/Cetirizine CBHP Impurity NLT 95%
    Cetirizine EP Impurity A/Cetirizine CBHP Impurity NLT 95%
    59872-62-1
    View Details
  • 90717-17-2 Ketamine Impurity-C NLT 95%
    90717-17-2 Ketamine Impurity-C NLT 95%
    90717-17-2
    View Details
  • .2005-04-1 N-Nitroso hydroxy Cetrizine EP Impurity-A NLT 95%
    .2005-04-1 N-Nitroso hydroxy Cetrizine EP Impurity-A NLT 95%
    .2005-04-1
    View Details
  • 145773-22-1 Lantanoprost rc B NLT 95%
    145773-22-1 Lantanoprost rc B NLT 95%
    145773-22-1
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.